A carregar...
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
The Spike protein is the target of both antibody‐based therapeutics (convalescent plasma, polyclonal serum, monoclonal antibodies) and vaccines. Mutations in Spike could affect efficacy of those treatments. Hence, monitoring of mutations is necessary to forecast and readapt the inventory of therapeu...
Na minha lista:
| Publicado no: | Rev Med Virol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250244/ https://ncbi.nlm.nih.gov/pubmed/33724631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmv.2231 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|